emergency sign
HIV PEP (Post-Exposure Prophylaxis for HIV infection) stands as a beacon of hope, offering a proactive measure to prevent HIV infection within 72 hours after a possible exposure. In an era where the pursuit of health and well-being takes precedence, understanding how to navigate potential HIV exposure is crucial for sexually active individuals.
This post article is mainly about overall basic information about HIV PEP: Post-Exposure Prophylaxis for HIV. If you would like to get HIV PEP medication now, contact us or check out more information about HIV PEP service at H.U.M. Clinic. Please visit this post Get HIV PEP Bangkok: Post-Exposure Prophylaxis for HIV.

HIV Post Exposure Prophylaxis, or PEP, is a medical intervention designed to prevent HIV infection after a person has been potentially exposed to the virus. This critical prevention strategy involves a regimen of antiretroviral drugs taken within 72 hours of exposure, ideally within 4 hours and preferably within 24-48 hours.

PEP works by interfering with the virus’s ability to replicate within the body’s cells. According to guidelines from the CDC, the International Antiviral Society-USA, and the European AIDS Clinical Society, the standard course lasts for 28 days. This duration is critical to ensure the medication has enough time to effectively combat any HIV virus that may have entered the body.

Incorporating PEP into HIV prevention strategies offers a second chance at prevention for those who have had a recent high-risk exposure to HIV. It is an essential component of comprehensive HIV prevention, alongside other methods such as Pre-Exposure Prophylaxis (PrEP) for those at ongoing risk, condom use, and regular HIV testing. While PEP is highly effective, it is not a substitute for these other prevention methods but rather a critical safety net in emergency situations.

the redlight district area stating the orange and red color of sex shop

In the journey of HIV prevention, understanding the right moment to consider Post Exposure Prophylaxis (PEP) is crucial. PEP serves as an emergency intervention. It also actห as a powerful shield against HIV infection when taken within the critical window after potential exposure. But knowing exactly when to seek out PEP is essential for its effectiveness.

High-risk exposures to HIV include situations where an individual has had unprotected sexual contact, including vaginal or anal intercourse, with a person known to have HIV or whose HIV status is unknown but could be at risk. Other scenarios include:

  • Unprotected receptive oral sex with someone at risk of HIV.
  • Sharing needles, syringes, or other equipment to inject drugs.
  • Experiencing accidents where a condom broke or slipped during intercourse.
  • Expose to HIV through occupational hazards, such as needlestick injuries.
  • Expose to mucous membranes, blood, or bodily fluids, unsure to be source of HIV virus.

The efficacy of PEP diminishes over time post-exposure, making the 72-hour window following a potential HIV exposure critical. The Centers for Disease Control and Prevention (CDC) underscores the importance of initiating PEP as soon as possible, ideally within 24 hours. The sooner, the better the chance of preventing HIV infection. Consider the nature of the exposure and the HIV status of any involved partner. When in doubt, seeking immediate medical advice can help determine if PEP is the right course of action.

The effectiveness of PEP in preventing HIV infection is significant when started within 72 hours of exposure and taken consistently for 28 days. It can be estimated about 70-80%.  Studies “Updated Guidelines for the Use of Post-Exposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV—United States, 2016” have shown that the medication can significantly reduce the risk of HIV infection if the regimen is adhered to fully. A landmark study for the effectiveness of PEP is the Brussels Needlestick Study, which found a substantial reduction in HIV transmission among healthcare workers who received PEP after occupational exposure. 

HIV Post-Exposure Prophylaxis (PEP) can be a crucial intervention for preventing HIV infection after potential exposure. However, its effectiveness can be compromised by various factors. Understanding these causes is essential to ensuring the best possible outcomes when using PEP.

  • False Positive HIV Test Before PEP Course: If the initial HIV test is a false positive, PEP may be ineffective from the start.
  • Lack of HIV Testing Before Starting PEP: Obtaining PEP medication from unauthorized sources, such as the black market, pharmacies, or unethical online clinics, without proper HIV testing can lead to failure.
  • Delayed Start of PEP: PEP is most effective when started within 72 hours of exposure. Delaying beyond this window significantly reduces its efficacy.
  • Inconsistent PEP Usage: Skipping doses or not taking PEP daily can lead to insufficient drug levels in the body, reducing its effectiveness.
  • Premature Discontinuation: Stopping PEP before completing the full 28-day course can result in incomplete protection.
  • Drug-Resistant HIV: Infection with a strain of HIV that is resistant to the medications used in PEP can lead to treatment failure.
By addressing these factors and ensuring proper usage and follow-up, the likelihood of successful HIV prevention with PEP can be significantly increased.

While PEP (Post-Exposure Prophylaxis) is generally safe, there are potential side effects that can vary depending on the specific medication regimen. It’s important to be aware of these possible side effects and consult with healthcare providers throughout the course of PEP to manage any adverse effects.

  • Nausea and Vomiting: The most frequently reported side effects and can occur soon after starting PEP.
  • Diarrhea: Many individuals experience gastrointestinal disturbances, including diarrhea, which can vary in severity.
  • Fatigue: Feeling unusually tired or weak is a common side effect that can affect daily activities.
  • Headache: Some people may experience persistent or intermittent headaches during the treatment.
  • Dizziness: Dizziness or lightheadedness can also occur, impacting balance and overall comfort.
  • Liver Toxicity: In rare cases, PEP medications can cause liver damage, necessitating regular monitoring of liver function.
  • Kidney Toxicity: Kidney function can also be affected, requiring periodic blood tests to ensure proper renal health.
  • Allergic Reactions: Although uncommon, allergic reactions to PEP medications can occur and may require immediate medical attention.

Before initiating Emergency PEP, certain baseline tests are recommended to assess the individual’s suitability for the medication and to rule out any existing infections. These typically include:

  • HIV Test: An initial test to confirm the individual’s HIV status before starting PEP. Consider other treatment options if the test shows a positive result.
  • Hepatitis B Test: Since PEP medications can also suppress hepatitis B virus. Testing is important before starting the medication.
  • Hepatitis C Test: The current Hepatitis C infection could result in False negative of HIV tests due to delayed antibody response.
  • Kidney and Liver Function Tests: The antiretrovirals can affect liver and kidney function if you have current kidney and liver condition.
  • Pregnancy Test: For women of childbearing age, to ensure that PEP medication choices are safe in case of pregnancy.
This is the H.U.M. Clinic which located at Asok, Bangkok.
After completing the regimen, follow-up testing is essential to determine if the PEP was effective in preventing HIV infection. The follow-up typically includes:
  • Syphilis test: Syphilis infection may develop early at 3 weeks from Exposure. The common symptoms are rash and genital ulcer or oral ulcer.
  • PCR multiplex: Location specific STD infection may happen as the earliest as 5-7 days after exposure such as Gonorrhrea, Chlamydia, Mycoplasma, Herpes.
  • HIV Test: Conducted at several intervals, such as after 4-6 weeks, 3 months, for the 99.8% + accuracy.
  • Other STDs test: Having been at risk of HIV is also in risk of other STDs, and it is asymptomatic. Ensure to check for other systemic STD like Syphilis, Hepatitis.
  • PCR multiplex: Location specific STD infection can happen without showing symptoms. Screening after finishing PEP is also recommended.
  • Kidney and Liver Function Tests: To monitor any potential side effects from the medication on liver and kidney health, if indicated.

    Remark: After having experienced sexual risk events, there’s a chance it could happen again. HIV PrEP (Pre-Exposure Prophylaxis) could prevent you from taking medication for the whole 28 days, and it has very high efficacy (86-99%).